Primary record
2,10,12,16,18-NONADECAPENTAENOIC ACID, 19-((2S,3S)-3,6-DIHYDRO-3-METHYL-6-OXO-2H-PYRAN-2-YL)-17-ETHYL-6-HYDROXY-9-(HYDROXYMETHYL)-3,5,7,11,15-PENTAMETHYL-8-OXO-, (2E,5S,6R,7S,9S,10E,12E,15R,16Z,18E)-
- 库存
- 6,327 克
- 纯度
- 99.8 %
- CAS
- 92090-94-3
化合物标识与属性
- CAS
- 92090-94-3
- PubChem CID
- 11272917
- SMILES
- CC/C(=C/[C@H](C)C/C=C/C(=C/[C@@H](CO)C(=O)[C@@H](C)[C@@H]([C@@H](C)C/C(=C/C(=O)O)/C)O)/C)/C=C/[C@H]1[C@H](C=CC(=O)O1)C
- Canonical SMILES
- CCC(=C/[C@H](C)C/C=C/C(C)=C/[C@@H](CO)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C/C(C)=C/C(=O)O)/C=C/[C@@H]1OC(=O)C=C[C@@H]1C
名称与同义词
- Kazusamycin A
- Kazusamycin
- Hydroxyelactocin
- Antibiotic 81-484
- (-)-KazusamycinA
- Antibiotic CL1957B
- 3-HYDROXYLEPTOMYCIN B
- 16-hydroxyleptomycin B
- Antibiotic CL-1957B
- 92090-94-3
- RefChem:151049
- 9F2Y3169IP
- CL-1957B
- UNII-9F2Y3169IP
- CHEMBL207141
- DTXSID801098454
- orb1703285
- KAZUSAMYCIN A, (-)-
- SCHEMBL29420111
- DTXCID401530195
- CL 1957B
- PD-114721
- BBF-01887
- KAZUSAMYCIN A FROM STREPTOMYCES SP.
- ZINC43523785
- AKOS040745938
- C33-H48-O7
- PD 114721
- CID11272917
- J22.915F
- HY-130044
- CS-0104446
- (2E,5S,6R,7S,9S,10E,12E,15R,16Z,18E)-17-ethyl-6-hydroxy-9-(hydroxymethyl)-3,5,7,11,15-pentamethyl-19-[(2S,3S)-3-methyl-6-oxo-2,3-dihydropyran-2-yl]-8-oxononadeca-2,10,12,16,18-pentaenoic acid
- Q27896151
- (2E,5S,6R,7S,9S,10E,12E,15R,16Z,18E)-19-((2S,3S)-3,6-DIHYDRO-3-METHYL-6-OXO-2H-PYRAN-2-YL)-17-ETHYL-6-HYDROXY-9-(HYDROXYMETHYL)-3,5,7,11,15-PENTAMETHYL-8-OXO-2,10,12,16,18-NONADECAPENTAENOIC ACID
- (2E,5S,6R,7S,9S,10E,12E,15R,16Z,18E)-19-[(2S,3S)-3,6-Dihydro-3-methyl-6-oxo-2H-pyran-2-yl]-17-ethyl-6-hydroxy-9-(hydroxymethyl)-3,5,7,11,15-pentamethyl-8-oxo-2,10,12,16,18-nonadecapentaenoic acid
- (2E,5S,6R,7S,9S,10E,12E,15R,16Z,18E)-17-ethyl-6-hydroxy-9-(hydroxymethyl)-3,5,7,11,15-pentamethyl-19-((2S,3S)-3-methyl-6-oxo-2,3-dihydropyran-2-yl)-8-oxononadeca-2,10,12,16,18-pentaenoic acid
- (2E,5S,6R,7S,9S,10E,12E,15R,16Z,18E)-17-Ethyl-6-hydroxy-9-(hydroxymethyl)-3,5,7,11,15-pentamethyl-19-((2S,3S)-3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)-8-oxononadeca-2,10,12,16,18-pentaenoic acid
- (2E,5S,6R,7S,9S,10E,12E,15R,16Z,18E)-17-ethyl-6-hydroxy-9-(hydroxymethyl)-3,5,7,11,15-pentamethyl-19-[(2S,3S)-3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl]-8-oxononadeca-2,10,12,16,18-pentaenoic acid
- (2E,5S,6R,7S,9S,10E,12E,15R,16Z,18E)-19-(3,6-Dihydro-3beta-methyl-6-oxo-2H-pyran-2beta-yl)-17-ethyl-6-hydroxy-9-(hydroxymethyl)-3,5,7,11,15-pentamethyl-8-oxo-2,10,12,16,18-nonadecapentaenoic acid
- 2,10,12,16,18-NONADECAPENTAENOIC ACID, 19-((2S,3S)-3,6-DIHYDRO-3-METHYL-6-OXO-2H-PYRAN-2-YL)-17-ETHYL-6-HYDROXY-9-(HYDROXYMETHYL)-3,5,7,11,15-PENTAMETHYL-8-OXO-, (2E,5S,6R,7S,9S,10E,12E,15R,16Z,18E)-
- 2,10,12,16,18-Nonadecapentaenoic acid, 19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-17-ethyl-6-hydroxy-9-(hydroxymethyl)-3,5,7,11,15-pentamethyl-8-oxo-
- 2,10,12,16,18-Nonadecapentaenoic acid, 19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-17-ethyl-6-hydroxy-9-(hydroxymethyl)-3,5,7,11,15-pentamethyl-8-oxo-, (2E,10E,12E,16E,18E)-
- 2,10,12,16,18-Nonadecapentaenoic acid, 19-[(2S,3S)-3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl]-17-ethyl-6-hydroxy-9-(hydroxymethyl)-3,5,7,11,15-pentamethyl-8-oxo-, (2E,5S,6R,7S,9S,10E,12E,15R,16Z,18E)-